Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics

• Övriga skapare: Wink, Joachim (Utgivare, redaktör, sammanställare)
• Materialtyp: Elektronisk Bokavsnitt
• Språk: engelska
• Publicerad: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
• Ämnen: Research & information: general; Biology, life sciences; actinomycetes; antibiotic biosynthesis; silent biosynthetic pathways; γ-butyrolactones; HiTES; translation inhibitors; marine actinobacteria; Streptomyces sp.; enzyme inhibition; antimicrobial; antioxidant; cytotoxicity; GC-MS; pyrrolopyrazines; myxobacteria; antivirals; secondary metabolites; HIV; Ebola; hepatitis viruses; diversity; uncultured; new antibiotics; Streptomyces; polyketides; secondary metabolite; polyketide synthases (PKSs)
• Länkar: DOAB: download the publication; DOAB: description of the publication

Sammanfattning

Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units.

Fysisk beskrivning

1 electronic resource (270 p.)

ISBN

books978-3-03943-530-2
9783039435296
9783039435302

Tillgång

Open Access